Gene Therapy Aims to Silence Hepatitis B Virus DNA
Researchers are testing an experimental therapy called CRMA-1001 against hepatitis B. Instead of attacking the virus directly, it silences the viral DNA. This matters because current treatments rarely remove that DNA, which lets the virus come back.
Context
Context: Hepatitis B is a liver infection that can become chronic and raise the risk of liver cancer, and it is common in India. Most current drugs control the virus rather than clear it, so a true cure is a long-sought goal.
Burning Potato score: 67%